Senthil Karunakaran

492 total citations
6 papers, 384 citations indexed

About

Senthil Karunakaran is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Senthil Karunakaran has authored 6 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Biochemistry and 2 papers in Oncology. Recurrent topics in Senthil Karunakaran's work include Amino Acid Enzymes and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Senthil Karunakaran is often cited by papers focused on Amino Acid Enzymes and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Senthil Karunakaran collaborates with scholars based in United States. Senthil Karunakaran's co-authors include Puttur D. Prasad, Vadivel Ganapathy, Muthusamy Thangaraju, Selvakumar Elangovan, S Itagaki, David H. Munn, Patricia V. Schoenlein, Nagavedi S. Umapathy, Takahiro Hatanaka and Sabarish Ramachandran and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Cancer Research.

In The Last Decade

Senthil Karunakaran

6 papers receiving 382 citations

Peers

Countries citing papers authored by Senthil Karunakaran

Since Specialization

Citations

This map shows the geographic impact of Senthil Karunakaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senthil Karunakaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senthil Karunakaran more than expected).

Fields of papers citing papers by Senthil Karunakaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Senthil Karunakaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senthil Karunakaran. The network helps show where Senthil Karunakaran may publish in the future.

Co-authorship network of co-authors of Senthil Karunakaran

This figure shows the co-authorship network connecting the top 25 collaborators of Senthil Karunakaran. A scholar is included among the top collaborators of Senthil Karunakaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Senthil Karunakaran. Senthil Karunakaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Nrbf2 Protein Suppresses Autophagy by Modulating Atg14L Protein-containing Beclin 1-Vps34 Complex Architecture and Reducing Intracellular Phosphatidylinositol-3 Phosphate Levels 2014 ·Journal of Biological Chemistry ·Yu Zhong, (unknown), Lin Jin, (unknown), Senthil Karunakaran, You‐Jun Fu, (unknown), Heidi L. Weiss, Brian T. Chait, Qing Jun Wang	56
2	SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer 2011 ·Journal of Biological Chemistry ·Senthil Karunakaran, Sabarish Ramachandran, Veena Coothankandaswamy, Selvakumar Elangovan, Ellappan Babu, Sudharsan Periyasamy‐Thandavan, Ashish Gurav, Jaya P. Gnana‐Prakasam, Nagendra Singh, Patricia V. Schoenlein, Puttur D. Prasad, Muthusamy Thangaraju, Vadivel Ganapathy	162
3	Abstract 4838: Alpha-methyltryptophan, a blocker of the amino acid transporter SLC6A14, induces autophagy and apoptosis in SLC6A14-positive breast cancer and colon cancer cell lines 2010 ·Cancer Research ·Senthil Karunakaran, Patricia V. Schoenlein, Muthusamy Thangaraju, Puttur D. Prasad, Vadivel Ganapathy	1
4	Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3‐bromopyruvate 2009 ·Cancer ·Muthusamy Thangaraju, Senthil Karunakaran, S Itagaki, Elangovan Gopal, Selvakumar Elangovan, Puttur D. Prasad, Vadivel Ganapathy	55
5	Functional Identification of a Novel Transport System for Endogenous and Synthetic Opioid Peptides in the Rabbit Conjunctival Epithelial Cell Line CJVE 2008 ·Pharmaceutical Research ·Sudha Ananth, Senthil Karunakaran, Pamela M. Martin, Chandrasekharam N. Nagineni, John J. Hooks, Sylvia B. Smith, Puttur D. Prasad, Vadivel Ganapathy	10
6	Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy 2008 ·Biochemical Journal ·Senthil Karunakaran, Nagavedi S. Umapathy, Muthusamy Thangaraju, Takahiro Hatanaka, S Itagaki, David H. Munn, Puttur D. Prasad, Vadivel Ganapathy	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact